Oral delta 9-tetrahydrocannabinol improved refractory Gilles de la Tourette syndrome in an adolescent by increasing intracortical inhibition: a case report.
Standard
Oral delta 9-tetrahydrocannabinol improved refractory Gilles de la Tourette syndrome in an adolescent by increasing intracortical inhibition: a case report. / Hasan, Alkomiet; Rothenberger, Aribert; Münchau, Alexander; Wobrock, Thomas; Falkai, Peter; Roessner, Veit.
in: J CLIN PSYCHOPHARM, Jahrgang 30, Nr. 2, 2, 2010, S. 190-192.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Oral delta 9-tetrahydrocannabinol improved refractory Gilles de la Tourette syndrome in an adolescent by increasing intracortical inhibition: a case report.
AU - Hasan, Alkomiet
AU - Rothenberger, Aribert
AU - Münchau, Alexander
AU - Wobrock, Thomas
AU - Falkai, Peter
AU - Roessner, Veit
PY - 2010
Y1 - 2010
N2 - To describe the clinical course of the Delta 9-tetrahydrocannabinol (Delta 9-THC) treatment of a boy with Gilles de la Tourette Syndrome (TS) and comorbid attention-deficit/hyperactivity disorder (ADHD) in relation to Delta 9-THC plasma levels and intracortical inhibition measured by transcranial magnetic stimulation.
AB - To describe the clinical course of the Delta 9-tetrahydrocannabinol (Delta 9-THC) treatment of a boy with Gilles de la Tourette Syndrome (TS) and comorbid attention-deficit/hyperactivity disorder (ADHD) in relation to Delta 9-THC plasma levels and intracortical inhibition measured by transcranial magnetic stimulation.
KW - Humans
KW - Male
KW - Adolescent
KW - dosage
KW - Neural Inhibition drug effects
KW - Administration, Oral
KW - Transcranial Magnetic Stimulation methods
KW - Cerebral Cortex drug effects
KW - Tetrahydrocannabinol administration
KW - Tourette Syndrome blood
KW - Humans
KW - Male
KW - Adolescent
KW - dosage
KW - Neural Inhibition drug effects
KW - Administration, Oral
KW - Transcranial Magnetic Stimulation methods
KW - Cerebral Cortex drug effects
KW - Tetrahydrocannabinol administration
KW - Tourette Syndrome blood
M3 - SCORING: Zeitschriftenaufsatz
VL - 30
SP - 190
EP - 192
JO - J CLIN PSYCHOPHARM
JF - J CLIN PSYCHOPHARM
SN - 0271-0749
IS - 2
M1 - 2
ER -